105
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Association of Lymphocyte to Monocyte Ratio and Risk of in-Hospital Mortality in Patients with Cardiogenic Shock: A Propensity Score Matching Study

, &
Pages 4459-4468 | Published online: 12 Aug 2021

References

  • Kolte D, Khera S, Aronow W, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3(1):e000590. doi:10.1161/JAHA.113.000590
  • Lim H, Howell N. Cardiogenic shock due to end-stage heart failure and acute myocardial infarction. Shock. 2018;50(2):167–172. doi:10.1097/SHK.0000000000001052
  • Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;44(6):760–773. doi:10.1007/s00134-018-5214-9
  • De Luca L, Olivari Z, Farina A, et al. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail. 2015;17(11):1124–1132. doi:10.1002/ejhf.339
  • Thom T, Haase N, Rosamund W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2006;113:e85–e151. doi:10.1161/CIRCULATIONAHA.105.171600
  • Thiele H, Schuler G. Cardiogenic shock: to pump or not to pump? Eur Heart J. 2009;30(4):389–390. doi:10.1093/eurheartj/ehp030
  • Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–1296. doi:10.1056/NEJMoa1208410
  • Islam MS, Panduranga P, Al-Mukhaini M, et al. In-hospital outcome of patients with cardiogenic shock complicating acute myocardial infarction: results from Royal Hospital Percutaneous Coronary Intervention Registry, Oman. Oman Med J. 2016;31(1):46–51. doi:10.5001/omj.2016.09
  • Liu CH, Kuo SW, Hsu LM, et al. Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach. J Transl Med. 2016;14:114. doi:10.1186/s12967-016-0869-x
  • Fuernau G, Poenisch C, Eitel I, et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Eur J Heart Fail. 2014;16(8):880–887. doi:10.1002/ejhf.117
  • Pöss J, Fuernau G, Denks D, et al. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock–a biomarker substudy of the IABP-SHOCK II-Trial. Eur J Heart Fail. 2015;17(11):1152–1160. doi:10.1002/ejhf.342
  • Fuernau G, Pöss J, Denks D, et al. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Crit Care. 2014;18(6):713. doi:10.1186/s13054-014-0713-8
  • Peng Y, Huang W, Shi Z, Chen Y, Ma J. Positive association between systemic immune-inflammatory index and mortality of cardiogenic shock. Clin Chim Acta. 2020;511:97–103. doi:10.1016/j.cca.2020.09.022
  • Piotrowski D, Sączewska-Piotrowska A, Jaroszewicz J, Boroń-Kaczmarska A. Lymphocyte-to-monocyte ratio as the best simple predictor of bacterial infection in patients with liver cirrhosis. Int J Environ Res Public Health. 2020;17(5):1727. doi:10.3390/ijerph17051727
  • Li S, Liu K, Zhang R, et al. Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2018;4(3):148–153. doi:10.1136/svn-2018-000180
  • Tan D, Fu Y, Tong W, Li F. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg. 2018;55:128–138. doi:10.1016/j.ijsu.2018.05.030
  • Gary T, Pichler M, Belaj K, et al. Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract. 2014;68(12):1483–1487. doi:10.1111/ijcp.12495
  • Wang Q, Ma J, Jiang Z, Wu F, Ping J, Ming L. Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction. Medicine. 2017;96(34):e7897. doi:10.1097/MD.0000000000007897
  • Silva N, Bettencourt P, Guimarães JT. The lymphocyte-to-monocyte ratio: an added value for death prediction in heart failure. Nutr Metab Cardiovasc Dis. 2015;25(11):1033–1040. doi:10.1016/j.numecd.2015.07.004
  • Chen Y, Lin Y, Zhang H, Peng Y, Li S, Huang X. Relationship of platelet counts and inflammatory markers to 30-day mortality risk in patients with acute type A aortic dissection. Biomed Res Int. 2020;2020:1057496. doi:10.1155/2020/1057496
  • Johnson A, Bulgarelli L, Pollard T, Horng S, Celi LA, Mark R. MIMIC-IV (version 0.4). PhysioNet; 2020.
  • Harjola VP, Lassus J, Sionis A, et al.; CardShock Study Investigators; GREAT network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–509. doi:10.1002/ejhf.260
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
  • Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–774. doi:10.1001/jama.2016.0288
  • Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–2963. doi:10.1001/jama.1993.03510240069035
  • Le Gall JR, Klar J, Lemeshow S, et al. The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA. 1996;276(10):802–810. doi:10.1001/jama.270.24.2957
  • Chen ZQ, Yu XS, Mao LJ, et al. Prognostic value of neutrophil-lymphocyte ratio in critically ill patients with cancer: a propensity score matching study. Clin Transl Oncol. 2021;23(1):139–147. doi:10.1007/s12094-020-02405-8
  • Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi:10.1093/eurheartj/ehx393
  • van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–e268. doi:10.1161/CIR.0000000000000525
  • Geppert A, Dorninger A, Delle-Karth G, et al. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2006;34(8):2035–2042. doi:10.1097/01.CCM.0000228919.33620.D9
  • Appoloni O, Dupont E, Vandercruys M, et al. Association between the TNF-2 allele and a better survival in cardiogenic shock. Chest. 2004;125(6):2232–2237. doi:10.1378/chest.125.6.2232
  • Debrunner M, Schuiki E, Minder E, et al. Proinfammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol. 2008;97(5):298–305. doi:10.1007/s00392-007-0626-5
  • Cuinet J, Garbagnati A, Rusca M, et al. Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases. Sci Rep. 2020;10(1):7639. doi:10.1038/s41598-020-64702-0
  • Prondzinsky R, Unverzagt S, Lemm H, et al. Interleukin-6, −7, −8 and −10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101(5):375–384. doi:10.1007/s00392-011-0403-3
  • Peng Y, Wang J, Xiang H, et al. Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock: a cohort study. Med Sci Monit. 2020;26:e922167. doi:10.12659/MSM.922167
  • Cherfane CE, Gessel L, Cirillo D, Zimmerman MB, Polyak S. Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity. Inflamm Bowel Dis. 2015;21(8):1769–1775. doi:10.1097/MIB.0000000000000427
  • Ocana A, Nieto-Jiménez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017;16(1):137. doi:10.1186/s12943-017-0707-7
  • Song Q, Pan R, Jin Y, et al. Lymphocyte-to-monocyte ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke. Neurol Sci. 2020;41(9):2511–2520. doi:10.1007/s10072-020-04355-z
  • Spiesshoefer J, Boentert M, Tuleta I, Giannoni A, Langer D, Kabitz HJ. Diaphragm involvement in heart failure: mere consequence of hypoperfusion or mediated by hf-related pro-inflammatory cytokine storms? Front Physiol. 2019;10:1335. doi:10.3389/fphys.2019.01335
  • Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, Herndon DN. IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med. 2002;8(5):238–246. doi:10.1007/BF03402149